← All organizations

Biovitrum AB

For profit

Also known as: BIOVITRUM AB | Biovitrum AB (publ)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Apr 1, 2008

Acquired by Swedish Orphan Biovitrum → Advent International on Jan 1, 2010

Timeline

2000s

Jun 1, 2001
Biovitrum AB— Founded
Dec 15, 2004
palifermin— Marketing Organization
Aug 22, 2005
Arexis AB— Acquired

2010s

Jan 1, 2010
Swedish Orphan Biovitrum— Acquired By

2020s

Sep 8, 2021
Advent International— Now

Drugs by trial phase (3 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

palifermin

Phase 2 (1 own, 0 via acquisition)

bile-salt-stimulated lipase

Phase 1 (1 own, 0 via acquisition)

heparin

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Arexis AB

Recent trials (5)

NCT00658905Study directorPhase 2Apr 1, 2008
NCT00659243Study directorPhase 2Mar 1, 2008
NCT00540332Study directorPhase 1/Phase 2Oct 1, 2007
NCT00352703Study directorPhase 4Apr 1, 2006
NCT00361348Study directorPhase 1Dec 1, 2005

Details

Founded: Stockholm, SE Jun 1, 2001
Last known activity: Apr 1, 2008